Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer – a population-based cohort study in Sweden

Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer – a population-based cohort study in Sweden

Background: In a previous study, we explored real-world programmed death-ligand 1 (PD-L1) testing and treatment patterns for patients with advanced non-small cell lung cancer (NSCLC) in the era of immune-oncology. The present study aimed to investigate overall survival (OS) with PD-(L)1 inhibitors w...

Full description

Saved in:
Bibliographic Details
Main Authors: Gunnar Wagenius, Anders Vikström, Anders Berglund, Stina Salomonsson, Goran Bencina, Xiaohan Hu, Diana Chirovsky, Hans Brunnström
Format: Article
Language:English
Published: Medical Journals Sweden 2025-03-01
Series:Acta Oncologica
Subjects:
combination therapy
immune checkpoint inhibitor
monotherapy
overall survival
PD-L1
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/42746
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://medicaljournalssweden.se/actaoncologica/article/view/42746

Similar Items